Capital Increase / Dilution2026-07-02

Paid-in Capital Increase: Payment & Listing Dates Amended

TER

테라사이언스

073640

-0.15

Signal Score

52CNeutral
Score52 / 100

Historical Avg Return (5d)

+0.26%

Data Coverage

100%n=2445

Risk-adjusted indicator based on 2445 historical DART filings. For informational purposes only — not investment advice.

Financial Impact

NEUTRAL

Key Numbers

  • • New Payment Date: July 30, 2026 (originally July 2, 2026)
  • • New Listing Date: August 20, 2026 (originally July 28, 2026)
  • • New Share Issuance Price: 100 KRW per share (based on DCF valuation)
  • • Post-Dilution Major Shareholder: Seojin Panji Co., Ltd. (23.50% stake)
  • • Previous Major Shareholder: Weplus Investment Association (10.14% stake)

AI Analysis Summary

TERA SCIENCE Co.,LTD has amended its Material Fact Report regarding a paid-in capital increase. The payment date for the new shares has been postponed from July 2, 2026, to July 30, 2026, and the new listing date from July 28, 2026, to August 20, 2026. The issuance price per share is set at 100 KRW, determined by Samdo Accounting Firm using a Discounted Cash Flow (DCF) method, as the company's stock trading is currently suspended due to delisting concerns. This capital increase is intended for financial structure improvement and operational funds. Upon completion, Seojin Panji Co., Ltd. is expected to become the largest shareholder with a 23.50% stake, replacing Weplus Investment Association (10.14%). The newly issued shares will be subject to a 1-year lock-up period.

Track Korean Market Signals — Free

Sign up free to access live disclosures, AI analysis, and event filters.

Public Beta · No credit card required

This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.

AI-processed analysis. Based on: [기재정정]주요사항보고서(유상증자결정). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.